Dehydroandrographolide alleviates rheumatoid arthritis by inhibiting neutrophil activation via LMIR3 in collagen induced arthritis rats

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi: 10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Chua-Aguilera CJ, Moller B, Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides. Clin Rev Allergy Immunol. 2017 Dec;53(3):371–393. doi: 10.1007/s12016-017-8632-5
   PubMed Web of Science ®Google Scholar
• Semb AG, Ikdahl E, Wibetoe G, et al. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol. 2020 Jul;16(7):361–379 doi: 10.1038/s41584-020-0428-y
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang J, Lau J, et al. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019 Oct;15(10):581–596. doi: 10.1038/s41584-019-0275-x
   PubMed Web of Science ®Google Scholar
• Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care. 2018 Jun;45(2):237–255. doi: 10.1016/j.pop.2018.02.010
   PubMed Web of Science ®Google Scholar
• Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019 Jan 1;170(1):ITC1–ITC16. doi: 10.7326/AITC201901010
   PubMed Web of Science ®Google Scholar
• Song G, Feng T, Zhao R, et al. CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2019 Dec;78(12):1632–1641. doi: 10.1136/annrheumdis-2019-215473
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018 Feb 8;4(1):18001. doi: 10.1038/nrdp.2018.1
   PubMedGoogle Scholar
• Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 Dec;10(13):4025–31. doi: 10.1002/j.1460-2075.1991.tb04978.x
   PubMed Web of Science ®Google Scholar
• Wang BL, Sun W, Shi ZC, et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg. 2010 Jul;130(7):859–65. doi: 10.1007/s00402-009-0939-0
   PubMed Web of Science ®Google Scholar
• Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014 Oct;10(10):593–601. doi: 10.1038/nrrheum.2014.80
   PubMed Web of Science ®Google Scholar
• O’Neil LJ, Kaplan MJ. Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease. Trends Mol Med. 2019 Mar;25(3):215–227. doi: 10.1016/j.molmed.2018.12.008
   PubMed Web of Science ®Google Scholar
• Tanaka D, Kagari T, Doi H, et al. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology. 2006 Oct;119(2):195–202. doi: 10.1111/j.1365-2567.2006.02424.x
   PubMed Web of Science ®Google Scholar
• Abbasi M, Mousavi MJ, Jamalzehi S, et al. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019 Jul;234(7):10018–10031. doi: 10.1002/jcp.27860
   PubMed Web of Science ®Google Scholar
• Buckley L, Humphrey MB, Solomon CG. Glucocorticoid-induced osteoporosis. N Engl J Med. 2018 Dec 27;379(26):2547–2556. doi: 10.1056/NEJMcp1800214
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012 Apr;41(2):183–90. doi: 10.1007/s12020-011-9580-0
   PubMed Web of Science ®Google Scholar
• Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020 Sep;17(9):574–584. doi: 10.1038/s41569-020-0366-z
   PubMed Web of Science ®Google Scholar
• Li J, Huang W, Zhang H, et al. Synthesis of andrographolide derivatives and their TNF-α and IL-6 expression inhibitory activities. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6891–6894. doi: 10.1016/j.bmcl.2007.10.009
   PubMed Web of Science ®Google Scholar
• Gupta S, Mishra KP, Kumar B, et al. Andrographolide attenuates complete Freund’s adjuvant induced arthritis via suppression of inflammatory mediators and pro-inflammatory cytokines. J Ethnopharmacol. 2020 Oct 28;261:113022. doi: 10.1016/j.jep.2020.113022
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu Y, Liu YM, et al. Pharmacokinetics and tolerance of dehydroandrographolide succinate injection after intravenous administration in healthy Chinese volunteers. Acta Pharmacol Sin. 2012 Oct;33(10):1332–6. doi: 10.1038/aps.2012.79
   PubMed Web of Science ®Google Scholar
• Lu Z, Xie P, Zhang D, et al. 3-dehydroandrographolide protects against lipopolysaccharide-induced inflammation through the cholinergic anti-inflammatory pathway. Biochem Pharmacol. 2018 Dec;158:305–317. doi: 10.1016/j.bcp.2018.10.034
   PubMed Web of Science ®Google Scholar
• Chassagne F, Haddad M, Amiel A, et al. A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. Fitoterapia. 2018 Jun;127:226–236. doi: 10.1016/j.fitote.2018.02.021
   PubMed Web of Science ®Google Scholar
• Cai W, Wen H, Zhou Q, et al. 14-deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to its antiviral activity. Antiviral Res. 2020 Sep;181:104885. doi: 10.1016/j.antiviral.2020.104885
   PubMed Web of Science ®Google Scholar
• Valdiani A, Javanmard A, Talei D, et al. Microsatellite-based evidences of genetic bottlenecks in the cryptic species “andrographis paniculata nees”: a potential anticancer agent. Mol Biol Rep. 2013 Feb;40(2):1775–84. doi: 10.1007/s11033-012-2231-6.
   PubMed Web of Science ®Google Scholar
• Guo W, Liu J, Zhang Y, et al. Dehydroandrographolide inhibits mastitis by activating autophagy without affecting intestinal flora. Aging. 2020;12(14):14050–14065. doi: 10.18632/aging.103312
   PubMedGoogle Scholar
• Li X, Yuan K, Zhu Q, et al. Andrographolide ameliorates rheumatoid arthritis by regulating the apoptosis–NETosis balance of neutrophils. Int J Mol Sci. 2019 Oct 11;20(20):5035. doi: 10.3390/ijms20205035
   PubMed Web of Science ®Google Scholar
• Luo S, Li H, Liu J, et al. Andrographolide ameliorates oxidative stress, inflammation and histological outcome in complete Freund’s adjuvant-induced arthritis. Chem Biol Interact. 2020 Mar 1;319:108984. doi: 10.1016/j.cbi.2020.108984
   PubMed Web of Science ®Google Scholar
• Uchida S, Izawa K, Ando T, et al. CD300f is a potential therapeutic target for the treatment of food allergy. Allergy. 2020 Feb;75(2):471–474. doi: 10.1111/all.14034
   PubMed Web of Science ®Google Scholar
• Shiba E, Izawa K, Kaitani A, et al. Ceramide-CD300f binding inhibits lipopolysaccharide-induced skin inflammation. J Biol Chem. 2017 Feb 17;292(7):2924–2932. doi: 10.1074/jbc.M116.768366
   PubMed Web of Science ®Google Scholar
• Izawa K, Yamanishi Y, Maehara A, et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity. 2012 Nov 16;37(5):827–39. doi: 10.1016/j.immuni.2012.08.018
   PubMed Web of Science ®Google Scholar
• Matsukawa T, Izawa K, Isobe M, et al. Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation. Gut. 2016 May;65(5):777–87. doi: 10.1136/gutjnl-2014-308900
   PubMed Web of Science ®Google Scholar
• Scatizzi JC, Bickel E, Hutcheson J, et al. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum. 2006 Oct;54(10):3182–93. doi: 10.1002/art.22133
   PubMedGoogle Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010 Jan 30;31(2):455–61. doi: 10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Lill MA, Danielson ML. Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des. 2011 Jan;25(1):13–9. doi: 10.1007/s10822-010-9395-8
   PubMed Web of Science ®Google Scholar
• Pronk S, Pall S, Schulz R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013 Apr 1;29(7):845–54. doi: 10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Kim EJ, Lee SM, Suk K, et al. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines. Immunology. 2012 Mar;135(3):226–35. doi: 10.1111/j.1365-2567.2011.03528.x
   PubMed Web of Science ®Google Scholar
• O’Neil LJ, Barrera-Vargas A, Sandoval-Heglund D, et al. Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis. Sci Adv. 2020 Oct;6(44). doi: 10.1126/sciadv.abd2688
   PubMed Web of Science ®Google Scholar
• Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017 Jun 10;389(10086):2338–2348. doi: 10.1016/S0140-6736(17)31491-5
   PubMed Web of Science ®Google Scholar
• Wittkowski H, Foell D, af Klint E, et al. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis. 2007 Aug;66(8):1020–5. doi: 10.1136/ard.2006.061507
   PubMed Web of Science ®Google Scholar
• Yuan K, Zhu Q, Lu Q, et al. Quercetin alleviates rheumatoid arthritis by inhibiting neutrophil inflammatory activities. J Nutr Biochem. 2020 Oct;84:108454. doi: 10.1016/j.jnutbio.2020.108454
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim EJ, Suk K, et al. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J Immunol. 2011 Jun 1;186(11):6296–303. doi: 10.4049/jimmunol.1002184
   PubMed Web of Science ®Google Scholar
• Chung DH, Humphrey MB, Nakamura MC, et al. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol. 2003 Dec 15;171(12):6541–8. doi: 10.4049/jimmunol.171.12.6541
   PubMed Web of Science ®Google Scholar